Company Filing History:
Years Active: 2002
Title: The Innovations of Anne Mignot
Introduction
Anne Mignot is a notable inventor based in Braine-l'Alleud, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic agents. His work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Anne Mignot holds a patent for a CD40 signal blocking agent. This agent comprises, as an active ingredient, an s-triazolo[1,5-a]pyrimidine derivative or a pharmaceutically acceptable salt thereof. This innovative compound has the potential to play a crucial role in therapeutic applications, particularly in immunology.
Career Highlights
Throughout his career, Anne Mignot has been associated with UCB S.A., a leading global biopharmaceutical company. His work at UCB has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical research and development.
Collaborations
Some of his notable coworkers include Pierre P. Chatelain and Mark Taubman. Their collaborative efforts have contributed to the advancement of various projects within the company, showcasing the importance of teamwork in the field of innovation.
Conclusion
Anne Mignot's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science and therapeutic development.